The wearable device startup intends to use the cash to further develop its blood glucose tracking device as it prepares for launch in early 2016.

Sano, the US-based developer of a wearable sensor to track metabolic activity, has raised $10.25m in seed funding from backers including Intel Capital, semiconductor technology company Intel’s investment arm, TechCrunch reported on Friday.

The oversubscribed round also featured True Ventures, First Round Capital, Felicis Ventures, Elevation Capital, Floodgate and Rock Health. True Ventures and Felicis are also investors in Fitbit, the wearable health tracker producer that went public last week.

Sano has so far operated in stealth mode, but…